Ischemic and non-ischemic acute kidney injury cause hepatic damage

Slides:



Advertisements
Similar presentations
Hepatic Injury Secondary to Renal Ischemia-Reperfusion (I/R) Injury: Possible Role of Nitric Oxide Possible Role of Nitric Oxide P P 27 Abstract 1.Interaction.
Advertisements

MDM2 (murine double minute-2) links inflammation and tubular cell healing during acute kidney injury in mice  Shrikant R. Mulay, Dana Thomasova, Mi Ryu,
Volume 63, Issue 2, Pages (February 2003)
Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-α produced by renal parenchymal cells  B. Zhang, G. Ramesh, C.C. Norbury, W.B. Reeves 
Volume 80, Issue 11, Pages (December 2011)
Volume 73, Issue 11, Pages (June 2008)
Volume 64, Issue 5, Pages (November 2003)
Volume 79, Issue 1, Pages (January 2011)
Progranulin protects against renal ischemia/reperfusion injury in mice
Volume 76, Issue 7, Pages (October 2009)
Li-Wen Lai, Kim-Chong Yong, Yeong-Hau H. Lien  Kidney International 
Y.-H.H. Lien, K.-C. Yong, C. Cho, S. Igarashi, L.-W. Lai 
Bax and Bak have critical roles in ischemic acute kidney injury in global and proximal tubule–specific knockout mouse models  Qingqing Wei, Guie Dong,
Volume 79, Issue 4, Pages (February 2011)
Volume 82, Issue 8, Pages (October 2012)
Volume 74, Issue 7, Pages (October 2008)
Volume 80, Issue 11, Pages (December 2011)
Adenosine A2A receptor activation on CD4+ T lymphocytes and neutrophils attenuates lung ischemia–reperfusion injury  Ashish K. Sharma, MBBS, Victor E.
Volume 58, Issue 2, Pages (August 2000)
Volume 75, Issue 3, Pages (February 2009)
Tetramethylpyrazine protects spinal cord and reduces inflammation in a rat model of spinal cord ischemia-reperfusion injury  Lihong Fan, MD, Kunzheng.
Volume 75, Issue 2, Pages (January 2009)
Volume 79, Issue 1, Pages (January 2011)
Volume 70, Issue 2, Pages (July 2006)
Volume 86, Issue 3, Pages (September 2014)
Volume 73, Issue 4, Pages (February 2008)
Volume 81, Issue 4, Pages (February 2012)
Autophagy in proximal tubules protects against acute kidney injury
JNK mediates hepatic ischemia reperfusion injury
Volume 70, Issue 3, Pages (August 2006)
Decreased renal ischemia–reperfusion injury by IL-16 inactivation
Volume 79, Issue 1, Pages (January 2011)
Gilbert R. Kinsey, Liping Huang, Amy L. Vergis, Li Li, Mark D. Okusa 
Volume 75, Issue 8, Pages (April 2009)
Volume 80, Issue 12, Pages (December 2011)
Volume 82, Issue 3, Pages (August 2012)
Volume 82, Issue 4, Pages (August 2012)
Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney  Kent Doi, Yoshifumi Suzuki, Akihide Nakao,
Progressive endothelin-1 gene activation initiates chronic/end-stage renal disease following experimental ischemic/reperfusion injury  Richard A. Zager,
Volume 83, Issue 3, Pages (March 2013)
Volume 73, Issue 12, Pages (June 2008)
Volume 80, Issue 8, Pages (October 2011)
Volume 63, Issue 2, Pages (February 2003)
Volume 85, Issue 1, Pages (January 2014)
Resistance to ischemic acute renal failure in the Brown Norway rat: A new model to study cytoprotection  David P. Basile, Deborah Donohoe, X.I.A. Cao,
Volume 56, Issue 2, Pages (August 1999)
Volume 56, Issue 3, Pages (September 1999)
Volume 73, Issue 11, Pages (June 2008)
Genetic deficiency of adiponectin protects against acute kidney injury
Volume 85, Issue 4, Pages (April 2014)
Volume 85, Issue 4, Pages (April 2014)
Volume 76, Issue 7, Pages (October 2009)
20-HETE in acute kidney injury
Volume 75, Issue 5, Pages (March 2009)
Induction of heat shock protein 70 inhibits ischemic renal injury
Volume 79, Issue 2, Pages (January 2011)
Volume 74, Issue 1, Pages (July 2008)
Volume 88, Issue 4, Pages (October 2015)
Volume 73, Issue 3, Pages (February 2008)
Volume 60, Issue 6, Pages (December 2001)
Volume 75, Issue 5, Pages (March 2009)
Volume 85, Issue 1, Pages (January 2014)
Volume 63, Issue 1, Pages (January 2003)
Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure  D.W. Johnson, B. Pat, D.A. Vesey, Z.
Volume 74, Issue 8, Pages (October 2008)
A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia–reperfusion injury  L.-W. Lai, K.-C. Yong,
Volume 75, Issue 5, Pages (March 2009)
Volume 85, Issue 1, Pages (January 2014)
Volume 75, Issue 8, Pages (April 2009)
Volume 54, Issue 2, Pages (August 1998)
Presentation transcript:

Ischemic and non-ischemic acute kidney injury cause hepatic damage Fereshteh Golab, Mehri Kadkhodaee, Maryam Zahmatkesh, Mehdi Hedayati, Hossein Arab, Rebecca Schuster, Kamyar Zahedi, Alex B. Lentsch, Manoocher Soleimani  Kidney International  Volume 75, Issue 8, Pages 783-792 (April 2009) DOI: 10.1038/ki.2008.683 Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 1 Serum creatinine and BUN in various experimental groups with renal injury. Serum creatinine (mg/100 ml; a) and blood urea nitrogen (BUN; mg/100 ml; b) were determined in all groups. Renal IRI led to a significant rise in serum creatinine and BUN relative to sham-operated animals, and bilateral nephrectomy led to a much higher elevation in serum creatinine and BUN levels. Bilat. neph, bilateral nephrectomy; IRI, ischemia–reperfusion injury. Results are the mean±s.e.m. *P<0.05 compared with sham. #P<0.05 compared with IRI 24 h. $P<0.05 compared with IRI 6 and 24 h and Bilat. neph 6 h (n=7). Kidney International 2009 75, 783-792DOI: (10.1038/ki.2008.683) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 2 Liver tumor necrosis factor (TNF)-α concentrations in various experimental groups with renal injury. The concentration of TNF-α increased significantly at 6 and 24 h after renal IRI or bilateral nephrectomy compared with sham-operated animals. The highest increase in TNF-α levels was observed at 24 h after bilateral nephrectomy. Bilat. neph, bilateral nephrectomy; IRI, ischemia–reperfusion injury. Results are the mean±s.e.m. *P<0.05 compared with sham. #P<0.05 compared with IRI 6 and 24 h and Bilat. neph 6 h (n=7). Kidney International 2009 75, 783-792DOI: (10.1038/ki.2008.683) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 3 Liver interleukin (IL)-10 in various experimental groups with renal injury. The concentration of IL-10 increased significantly at 6 and 24 h after renal IRI or bilateral nephrectomy compared with sham-operated animals. The highest increase in IL-10 levels was observed at 24 h after bilateral nephrectomy. Bilat. neph, bilateral nephrectomy; IRI, ischemia–reperfusion injury. Results are the mean±s.e.m. *P<0.05 compared with sham. #P<0.05 compared with IRI 6 and 24 h and bilat. neph 6 h (n=7). Kidney International 2009 75, 783-792DOI: (10.1038/ki.2008.683) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 4 Liver malondialdehyde (MDA) in various experimental groups with renal injury. MDA levels increased significantly at 6 h after reperfusion of the ischemic kidneys or bilateral nephrectomy compared with sham-operated animals. MDA levels also increased significantly 24 h after bilateral nephrectomy. Bilat. neph, bilateral nephrectomy; IRI, ischemia–reperfusion injury. Results are the mean±s.e.m. *P<0.05 compared with sham (n=7). Kidney International 2009 75, 783-792DOI: (10.1038/ki.2008.683) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 5 Liver GSH in various experimental groups with renal injury. As indicated, both IRI and bilateral nephrectomy caused a significant depletion of GSH levels relative to sham-operated groups. Bilat. neph, bilateral nephrectomy; IRI, ischemia–reperfusion injury. Results are the mean±s.e.m. *P<0.05 compared with sham (n=7). Kidney International 2009 75, 783-792DOI: (10.1038/ki.2008.683) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 6 Hepatic expression of spermidine/spermine N-acetyltransferase (SSAT) in rats subjected to kidney IRI or bilateral nephrectomy. Northern blot analyses were performed (30 μg/well total RNA) to examine the hepatic expression of SSAT in the kidney after IRI or bilateral nephrectomy. The expression of SSAT increased ∼3.5- and ∼2.5-fold at 6 h of reperfusion and bilateral nephrectomy, respectively (n=4; P<0.05 for each group vs sham-operated animals). Equal loading was confirmed by examination of the 18S rRNA bands (bottom). Kidney International 2009 75, 783-792DOI: (10.1038/ki.2008.683) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 7 Immunohistochemical staining of activated caspase-3 in hepatocytes. The number of hepatocytes displaying positive staining for activated caspase 3 was not significantly different at 6 h after nephrectomy or reperfusion injury (middle panels, top and bottom columns) relative to sham operated groups (left panels, top and bottom columns). At 24 h after bilateral nephrectomy animals showed significant increase in the number of hepatocytes displaying activated caspase 3 staining relative to sham (right panel, bottom row vs left panel, bottom row). Activated caspase 3 staining at 24 h after reperfusion injury was only mildly above baseline relative to sham (right panel, top row vs left panel, top row). Kidney International 2009 75, 783-792DOI: (10.1038/ki.2008.683) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 8 Liver histology at 6 and 24 h after sham operation (a and b), ischemia–reperfusion injury (c and d) and bilateral nephrectomy (e and f). Sham-operated rat had normal liver histology. At 6 h after reperfusion or bilateral nephrectomy, nuclear and cytoplasmic degenerative changes, cellular vacuolization, leukocyte infiltration and congestion were observed. At 24 h after reperfusion, the severity of injury was milder relative to 6 h. The severity of tissue injury was more evident at 24 h after bilateral nephrectomy, as manifested by the extent of cellular degenerative changes (black arrow), disintegrated cytoplasm, pyknotic and atypical nuclei, and dilated microsomes (black arrow head) and congestion (white arrow). Magnifications: × 400 in a–f. Kidney International 2009 75, 783-792DOI: (10.1038/ki.2008.683) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 9 Effect of GSH treatment on liver function and structure in kidney IRI. GSH treatment significantly decreased blood alanine aminotransferase (ALT) (a) and hepatic malondialdehyde (MDA) (b) levels and protected against structural damage to liver (c–e) in rats subjected to IRI. Sham-operated (c), IRI (d) and GSH-treated animals (e) are shown for comparison. Sham-operated rats had normal liver histology. At 6 h after reperfusion, nuclear and cytoplasmic degenerative changes, cellular vacuolization, leukocyte infiltration, and congestion were observed. IRI: ischemia–reperfusion injury. Results are the mean±s.e.m. *P<0.05 compared with sham (n=7). Magnification: × 400 in c–e. Kidney International 2009 75, 783-792DOI: (10.1038/ki.2008.683) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 10 Effect of 60 min renal ischemia/24 h reperfusion on liver function and structure. Comparison with 24 h bilateral nephrectomy. Subjecting the rats to 60 min renal ischemia followed by 24 h reperfusion led to a significant rise in serum creatinine (a) and blood urea nitrogen (BUN) (b) that was comparable with the level observed in 24 h bilateral nephrectomy group. Liver concentration of tumor necrosis factor (TNF)-α was increased in 60 min renal ischemia/24 h reperfusion group but did reach the same magnitude as in 24 h bilateral nephrectomy (c). The microscopic analysis of the structure of liver indicated that damage was less profound in 60 min ischemic/24 h reperfusion (e) relative to 24 h bilateral nephrectomy (f). Sham-operated rats had normal liver histology (d). Data used in these graphs for bilateral nephrectomy are the same as in Figures 1 and 2. Bilat. neph, bilateral nephrectomy; IRI 60: 60 min ischemia and 24 h reperfusion injury. Results are the mean±s.e.m. *P<0.05 compared with sham. #P<0.05 compared with IRI 60 (n=7). Magnification: × 400 in d–f. Kidney International 2009 75, 783-792DOI: (10.1038/ki.2008.683) Copyright © 2009 International Society of Nephrology Terms and Conditions